Medicine for treating myasthenia gravis
A technology for myasthenia gravis and drugs, which can be used in drug combinations, pharmaceutical formulations, and muscular system diseases to solve the problems of sequelae, long course of disease, and high costs.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0072] Embodiments of the invention:
[0073] When the unit of use is gram, it is an effective dosage for one day, and it is taken three times a day, which is a conventional way of taking medicine.
[0074] Weigh raw materials according to the following mass ratio (kg)
[0075] Ginseng: 7 Astragalus: 7 Atractylodes macrocephala: 3.5 Yam: 7
[0076] Jujube: 7 Radix Paeoniae Rubra: 3.5 Angelica: 3.5 Rhizoma Chuanxiong: 3.5
[0077] Tangerine peel: 3.5 Chicken gizzard: 3.5 Grain worms: 2.5 Cimicifuga: 1.5
[0078] Bupleurum: 1.5 Habitat: 3.5 Ligustrum lucidum: 12 Epimedium: 12.5
[0079] Nymph: 3.5 Keel: 3.5 Oyster: 7 Licorice: 3.5
[0080] Tablets are prepared by conventional Chinese patent medicine processing methods.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com